On February 11, 2019, Brian M. Posner gave notice to Cellectar Biosciences, Inc. (the “Company”) of his resignation as Chief Financial Officer, effective March 8, 2019. The Company has initiated a search to identify and recruit a new candidate for the role of Chief Financial Officer.
In connection with his resignation, Mr. Posner acknowledged that his resignation did not result from any disagreement regarding the Company’s financial reporting or accounting policies, procedures, estimates or judgments.
As filed in the SEC 8-K current report
WASHINGTON—The Office of the Comptroller of the Currency (OCC) today released enforcement actions taken against…
As Prepared for Delivery Good afternoon. It’s an honor to welcome President Clinton to Treasury today…
WASHINGTON – Today, as part of the 30th anniversary celebration of the Community Development Financial…
Treasury imposes sanctions on dozens of Russian banks, securities registrars, and finance officials; OFAC issues…
WASHINGTON—Acting Comptroller Michael J. Hsu today testified on the state of the federal banking system…
As Prepared for Delivery Thank you very much for the opportunity to be here today, and…